Joseph E. Burgents, Ph.D.
Affiliations: | 2010 | Microbiology & Immunology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Immunology, OncologyGoogle:
"Joseph Burgents"Parents
Sign in to add mentor| Jonathan S. Serody | grad student | 2010 | UNC Chapel Hill | |
| (Tumor-induced immune suppression of therapeutic cancer vaccines.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| van Deventer HW, Burgents JE, Wu QP, et al. (2010) The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells. Cancer Research. 70: 10161-9 |
| Carlson MJ, Fulton LM, Coghill JM, et al. (2010) L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 10: 2596-603 |
| Burgents JE, Moran TP, West ML, et al. (2010) The immunosuppressive tumor environment is the major impediment to successful therapeutic vaccination in Neu transgenic mice. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 482-91 |
| Coghill JM, Carlson MJ, Panoskaltsis-Mortari A, et al. (2010) Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells. Blood. 115: 4914-22 |
| Moran TP, Burgents JE, Long B, et al. (2007) Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice. Vaccine. 25: 6604-12 |